Andrea Antinori
Andrea Antinori
Director HIV/AIDS Unit - INMI - National Institute for Infectious Diseases L. Spallanzani, Roma
Verified email at inmi.it
Title
Cited by
Cited by
Year
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
DL Paterson, S Swindells, J Mohr, M Brester, EN Vergis, C Squier, ...
Annals of internal medicine 133 (1), 21-30, 2000
40832000
Updated research nosology for HIV-associated neurocognitive disorders
A Antinori, G Arendt, JT Becker, BJ Brew, DA Byrd, M Cherner, DB Clifford, ...
Neurology 69 (18), 1789-1799, 2007
24032007
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20052003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Mųller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
13632006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10382008
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ...
Aids 14 (5), 499-507, 2000
6902000
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.
Ammassari
6282002
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ...
Journal of acquired immune deficiency syndromes (1999) 28 (5), 445-449, 2001
6242001
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b …
B Clotet, J Feinberg, J Van Lunzen, MA Khuong-Josses, A Antinori, ...
The Lancet 383 (9936), 2222-2231, 2014
4642014
Late presentation of HIV infection: a consensus definition
A Antinori, T Coenen, D Costagiola, N Dedes, M Ellefson, J Gatell, ...
HIV medicine 12 (1), 61-64, 2011
4352011
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ...
The Lancet infectious diseases 11 (5), 363-371, 2011
3972011
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
3612019
Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons
A Ammassari, A Antinori, MS Aloisi, MP Trotta, R Murri, L Bartoli, ...
Psychosomatics 45 (5), 394-402, 2004
3582004
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors
V Tozzi, P Balestra, R Bellagamba, A Corpolongo, MF Salvatori, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (2), 174-182, 2007
3502007
Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.
F Starace, A Ammassari, MP Trotta, R Murri, P De Longis, C Izzo, ...
Journal of acquired immune deficiency syndromes (1999) 31, S136-9, 2002
3402002
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects
A De Luca, R Bugarini, AC Lepri, M Puoti, E Girardi, A Antinori, A Poggio, ...
Archives of internal medicine 162 (18), 2125-2132, 2002
3062002
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ...
Aids 16 (3), 369-379, 2002
2962002
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays …
A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ...
Neurology 48 (3), 687-694, 1997
2751997
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2572005
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ...
Aids 15 (12), 1483-1491, 2001
2572001
The system can't perform the operation now. Try again later.
Articles 1–20